Some scientists are confident that organs from genetically modified pigs will one day be routinely transplanted into humans. But substantial ethical questions remain.
Category: Clinical Trials
-
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
-
How an Activist Group Helped Torpedo MDMA Therapy
The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
-
What the Polio Vaccine Has Meant for Public Health
A lawyer working with Robert F. Kennedy Jr. has asked the F.D.A. to withdraw approval of the current shot because it hasn’t been tested against a placebo. Scientists say such a test would be unethical.
-
New Amgen Drug MariTide Shows Promising Weight Loss in Early Data
The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients.
-
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
-
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
-
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
-
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
-
Three MDMA Studies Are Retracted by Scientific Journal
The psychedelic treatment, for PTSD, was rejected last week by government regulators.
-
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.
-
Veterans and Lawmakers Lobby for Approval of MDMA Therapy
The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.